CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 4 Insider Changes in Ownership
Page 32 of 39 · 778 filings